Brian Andrew Mitchell, SVP, Operations at GenMark Diagnostics, Inc. (GNMK), sold 2,000 shares at $5.41 ($11K) on 2020-02-03, disclosed to the SEC on 2020-02-04.
Scheduled sale ($11k) by SVP, Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| GNMK | SELL | 2020-08-24 | $73K | — | Filing → |
| GNMK | SELL | 2020-08-20 | $1.4M | — | Filing → |
| GNMK | SELL | 2020-08-05 | $12K | — | Filing → |